pediatric8knovember107.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 1, 2007

Pediatric Prosthetics, Inc.
(Exact name of Registrant as specified in its charter)

Idaho 
000-51804 
68-0566694 
(State or other jurisdiction
File Number)
(Commission
Identification No.)
(IRS Employer of
incorporation)

12926 Willow Chase Drive, Houston, Texas 77070
(Address of principal executive offices)(Zip Code)

Registrant's telephone number, including area code: (281) 897-1108


  Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 



 CHANGES IN REGISTRANT’S CERTIFYING ACCOUNTANT.

Effective November 1, 2007, the client auditor relationship between Pediatric Prosthetics, Inc. (the "Company") and Malone & Bailey, PC, Certified Public Accountants ("Malone") was terminated as Malone & Bailey, PC was dismissed by the Company. Effective November 1, 2007, the Company engaged GBH CPAs, PC, Certified Public Accountants ("GBH") as its principal independent public accountant for the fiscal year ended June 30, 2008. The decision to change accountants was recommended, approved and ratified by the Company's Board of Directors effective November 1, 2007.

Malone's report on the financial statements of the Company for the fiscal years ended June 30, 2006 and June 30, 2007, and any later interim period, including the interim period up to and including the date the relationship with Malone ceased, did not contain any adverse opinion or disclaimer of opinion and was not qualified or modified as to uncertainty, audit scope or accounting principles except for concerns about the Company's ability to continue as a going concern.

In connection with the audit of the Company's fiscal years ended June 30, 2006 and June 30, 2007, and any later interim period, including the interim period up to and including the date the relationship with Malone ceased, there were no disagreements between Malone and the Company on a matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreement, if not resolved to the satisfaction of Malone would have caused Malone to make reference to the subject matter of the disagreement in connection with its report on the Company's financial statements.

There have been no reportable events as provided in Item 304(a)(iv) of Regulation S-B during the Company's fiscal years ended June 30, 2006 and June 30, 2007, and any later interim period, including the interim period up to and including the date the relationship with Malone ceased.

The Company has authorized Malone to respond fully to any inquiries of any new auditors hired by the Company relating to their engagement as the Company's independent accountant. The Company has requested that Malone review the disclosure and Malone has been given an opportunity to furnish the Company with a letter addressed to the Commission containing any new information, clarification of the Company's expression of its views, or the respect in which it does not agree with the statements made by the Company herein. Such letter is filed as an exhibit to this Report.

The Company has not previously consulted with GBH regarding either (i) the application of accounting principles to a specific completed or contemplated transaction; (ii) the type of audit opinion that might be rendered on the Company's financial statements; or (iii) a reportable event (as provided in Item 304(a)(iv)(B) of Regulation S-B) during the Company's fiscal years ended June 30, 2006 and June 30, 2007, and any later interim period, including the interim period up to and including the date the relationship with Malone ceased. GBH has reviewed the disclosure required by Item 304 (a) before it was filed with the Commission and has been provided an opportunity to furnish the Company with a letter addressed to the Commission containing any new information, clarification of the Company's expression of its views, or the respects in which it does not agree with the statements made by the Company in response to Item 304 (a). GBH did not furnish a letter to the Commission.

ITEM 9.01.
FINANCIAL STATEMENTS AND EXHIBITS

Exhibit Number
Description of Exhibit
 
 
16.1*
Letter from Malone & Bailey, PC
 
 
 


 


SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 
Pediatric Prosthetics, Inc.
 
 
Date: November 5, 2007
 
 
By: Kenneth W. Bean
 
Kenneth W. Bean
 
Chief Financial Officer